CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-04-03 | TOOMAN CRAIG A Exec VP Finance, CFO | Option exercise | +16,740 | 128,854 | ||
| 2009-04-03 | TOOMAN CRAIG A Exec VP Finance, CFO | Sale | −5,930 | $6.12 | $36K | 122,924 |
| 2009-04-03 | TOOMAN CRAIG A Exec VP Finance, CFO | Option exercise · Restricted Stock Units | −16,740 | 39,060 | ||
| 2009-04-03 | del Campo Ralph EVP, Technical Operations | Option exercise | +12,600 | 139,604.14 | ||
| 2009-04-03 | del Campo Ralph EVP, Technical Operations | Option exercise · Restricted Stock Units | −12,600 | 29,400 | ||
| 2009-04-03 | Davit Paul Stephen Exec. Vice Pres. HR | Option exercise | +9,570 | 71,442.17 | ||
| 2009-04-03 | Davit Paul Stephen Exec. Vice Pres. HR | Sale | −2,826 | $6.12 | $17K | 68,616.17 |
| 2009-04-03 | Davit Paul Stephen Exec. Vice Pres. HR | Option exercise · Restricted Stock Units | −9,570 | 22,330 | ||
| 2009-04-03 | HORAK IVAN D EVP, R&D, Chief Scientific Off | Option exercise | +19,860 | 128,977 | ||
| 2009-04-03 | HORAK IVAN D EVP, R&D, Chief Scientific Off | Sale | −7,035 | $6.12 | $43K | 122,924 |
| 2009-04-03 | HORAK IVAN D EVP, R&D, Chief Scientific Off | Option exercise · Restricted Stock Units | −19,860 | 46,340 | ||
| 2009-04-03 | BUCHALTER JEFFREY H Chairman of the Board & CEO | Option exercise | +59,430 | 548,664 | ||
| 2009-04-03 | BUCHALTER JEFFREY H Chairman of the Board & CEO | Shares withheld for taxes | −27,011 | $6.12 | $165K | 521,653 |
| 2009-04-03 | BUCHALTER JEFFREY H Chairman of the Board & CEO | Option exercise · Restricted Stock Units | −59,430 | 138,670 | ||
| 2009-01-17 | TOOMAN CRAIG A Exec VP Finance, CFO | Other acquisition | +8,333 | 119,112 | ||
| 2009-01-17 | TOOMAN CRAIG A Exec VP Finance, CFO | Other acquisition | +18,334 | 119,112 | ||
| 2009-01-17 | TOOMAN CRAIG A Exec VP Finance, CFO | Sale | −10,306 | $6.33 | $65K | 108,806 |
| 2009-01-02 | SALISBURY ROBERT C Director | Grant or award · Stock Option (Right to Buy) | +33,453 | 33,453 | ||
| 2009-01-02 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +33,453 | 33,453 | ||
| 2009-01-02 | Renfro Phillip M Director | Grant or award · Stock Option (Right to Buy) | +33,453 | 33,453 |
Page 19 of 25 · 488 trades